Evidence map›Paper›PMID 30665398›Full record

ArticleBMC medicine2019

From high to low malaria transmission in Zanzibar-challenges and opportunities to achieve elimination.

A Björkman, D Shakely, A S Ali, U Morris, H Mkali, A K Abbas, A-W Al-Mafazy, K A Haji, J Mcha, R Omar and 8 more

Open access · goldAbstract read
In one paragraph

Article in BMC medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 2 pooled it
13.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 2 syntheses or guidelines pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

A BjörkmanDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solnavägen 9, SE-171 77, Stockholm, Sweden. anders.bjorkman@ki.se.
D ShakelyDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solnavägen 9, SE-171 77, Stockholm, Sweden.
A S AliZanzibar Malaria Elimination Programme, Zanzibar, Tanzania.
U MorrisDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solnavägen 9, SE-171 77, Stockholm, Sweden.
H MkaliMEASURE Evaluation, Dar es Salaam, Tanzania.
A K AbbasZanzibar Malaria Elimination Programme, Zanzibar, Tanzania.
A-W Al-MafazyZanzibar Malaria Elimination Programme, Zanzibar, Tanzania.
K A HajiZanzibar Malaria Elimination Programme, Zanzibar, Tanzania.
J MchaZanzibar Malaria Elimination Programme, Zanzibar, Tanzania.
R OmarZanzibar Malaria Elimination Programme, Zanzibar, Tanzania.
J CookDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solnavägen 9, SE-171 77, Stockholm, Sweden.
K ElfvingDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solnavägen 9, SE-171 77, Stockholm, Sweden.
M PetzoldCentre for Applied Biostatistics, University of Gothenburg, Gothenburg, Sweden.
M C SachsBiostatistics Unit, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
B Aydin-SchmidtDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Solnavägen 9, SE-171 77, Stockholm, Sweden.
C DrakeleyLondon School of Hygiene and Tropical Medicine, London, UK.
M MsellemTraining and Research, Mnazi Mmoja Hospital, Zanzibar, Tanzania.
A MårtenssonDepartment of Women's and Children's Health, International Maternal and Child Health, Uppsala University, Uppsala, Sweden.
Zanzibar University · TZKarolinska Institutet · SELondon School of Hygiene & Tropical Medicine · GBUniversity of Gothenburg · SEUppsala University · SE

Funding

Medical Research Council MR/R010161/1
6 · The paper itself

Abstract

backgroundSubstantial global progress in the control of malaria in recent years has led to increased commitment to its potential elimination. Whether this is possible in high transmission areas of sub-Saharan Africa remains unclear. Zanzibar represents a unique case study of such attempt, where modern tools and strategies for malaria treatment and vector control have been deployed since 2003.

methodsWe have studied temporal trends of comprehensive malariometric indices in two districts with over 100,000 inhabitants each. The analyses included triangulation of data from annual community-based cross-sectional surveys, health management information systems, vital registry and entomological sentinel surveys.

resultsThe interventions, with sustained high-community uptake, were temporally associated with a major malaria decline, most pronounced between 2004 and 2007 and followed by a sustained state of low transmission. In 2015, the Plasmodium falciparum community prevalence of 0.43% (95% CI 0.23-0.73) by microscopy or rapid diagnostic test represented 96% reduction compared with that in 2003. The P. falciparum and P. malariae prevalence by PCR was 1.8% (95% CI 1.3-2.3), and the annual P. falciparum incidence was estimated to 8 infections including 2.8 clinical episodes per 1000 inhabitants. The total parasite load decreased over 1000-fold (99.9%) between 2003 and 2015. The incidence of symptomatic malaria at health facilities decreased by 94% with a trend towards relatively higher incidence in age groups > 5 years, a more pronounced seasonality and with reported travel history to/from Tanzania mainland as a higher risk factor. All-cause mortality among children < 5 years decreased by 72% between 2002 and 2007 mainly following the introduction of artemisinin-based combination therapies whereas the main reduction in malaria incidence followed upon the vector control interventions from 2006. Human biting rates decreased by 98% with a major shift towards outdoor biting by Anopheles arabiensis.

conclusionsZanzibar provides new evidence of the feasibility of reaching uniquely significant and sustainable malaria reduction (pre-elimination) in a previously high endemic region in sub-Saharan Africa. The data highlight constraints of optimistic prognostic modelling studies. New challenges, mainly with outdoor transmission, a large asymptomatic parasite reservoir and imported infections, require novel tools and reoriented strategies to prevent a rebound effect and achieve elimination.

Indexed as

AdolescentChildChild, PreschoolCross-Sectional StudiesFemaleHumansIncidenceInfantMalaria, FalciparumMalePrevalenceTanzania

Identifiers

PMID30665398
PMCPMC6341737
OpenAlexW2911448144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.